Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 43.6B | 37.7B | 35.5B | 33.8B |
Cost of revenue | 14.7B | 13.6B | 11.8B | 11.8B |
Gross profit | 28.9B | 24.1B | 23.6B | 21.9B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 10.9B | 9.6B | 9.8B | 9.1B |
Operating income | 6.0B | 2.9B | 2.2B | 1.8B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.1B | 2.2B | 2.3B | 2.4B |
Other income expense | — | — | — | — |
Pretax income | 4.9B | 1.6B | 984M | 11.5B |
Tax provision | 274M | 748M | 713M | 2.8B |
Net income | 4.6B | 811M | 271M | 8.6B |
Basic EPS | — | 0.2 | -0.1 | 5.5 |
Diluted EPS | — | 0.2 | -0.1 | 5.5 |
Basic average shares | — | 1.2B | 1.2B | 1.2B |
Diluted average shares | — | 1.2B | 1.2B | 1.2B |
EBITDA | 11.2B | 7.9B | 7.2B | 7.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.1B | -560M | -431M | -2.0B |
Preferred stock dividends | 0 | 0 | 0 | 0 |